Is Syncom formulations multibagger?
In my opinion, Syncom formulation is unlikely to be a multibagger. The topline as well as bottomline growth has been very low over the past few years. The return on equity is under 10. More importantly, the promoters have significantly trimmed their stake in the company.
Will Syncom Formulation grow?
The company has shown a good profit growth of 49.98\% for the Past 3 years. The company has shown a good revenue growth of 15.56\% for the Past 3 years. Company has a healthy Interest coverage ratio of 105.33. Company’s PEG ratio is 0.28.
What does Syncom Formulation does?
Currently Syncom manufactures and markets more than 300 pharmaceutical formulations products in various dosage forms like Tablets, Capsules, Liquids Orals, Liquid Vials and Ampoule Injections & Dry Vial injections, Dry Syrups, Ointments, Inhalers & Herbals. The company’s marketing network is expanding globally.
How do you know if a stock is multibagger?
Method to identify multibagger stocks.
- Identify Companies Management: Management plays a vital role in the growth of companies business.
- Competitiveness:
- Promoters Holding in the Company:
- Earnings Growth:
- Allocation of Funds:
- Future Growth:
What is the share price of Syncom Healthcare?
This represents the 52 week high and low price of the security….Key Metrics.
1 Month | 2.47 |
---|---|
3 Months | 0.81 |
6 Months | 0.73 |
1 Year | 0.43 |
3 Years | 1.24 |
What are the products of Syncom Formulation?
Syncom Formulations (india) Limited
- Antibiotics Drugs. Ciprofloxacin Hydrochloride Tablets USP 250 mg. Desloratidine Tablets 10 mg.
- Analgesics Medicine. Debedol Forte. Aceclofenac Tablets 100 mg.
- Antimalarial Drugs. Chloroquine Phosphate Tablets 250 mg.
- Gastrointestinal Drugs. Gastro Resistant Omeprazole Capsules BP 20 mg.
What are the products of Syncom Formulations?
What is a 10 bagger in stocks?
A 10-bagger is an investing term first used by famed Fidelity mutual fund manager, Peter Lynch, in the 1980s and 1990s. It describes a stock that returns a 1000\%.
Which share is multibagger after 10 years?
1] Bajaj Finance: The multibagger stock was around ₹64 to ₹65 in November 2011 whereas in April 2010 it was around ₹40 per share levels. Bajaj Finance share price today on NSE is ₹6780. So, this multibagger stock has surged more than 100 times in this period of 10 to 11 years.
What happened to Syncom Healthcare?
Net Loss of Syncom Healthcare reported to Rs 1.07 crore in the quarter ended March 2021 as against net loss of Rs 9.66 crore during the previous quarter ended March 2020. Sales declined 90.84\% to Rs 1.83 crore in the year ended March 2021 as against Rs 19.97 crore during the previous year ended March 2020.
Is Syncom A multibagger stock?
As far as Syncom formulation is concerned it is from pharmaceutical industry and your query seems to be a genuine one because we have a number of pharmaceutical stocks which have given multibagger return to its shareholders in past couple of years. We have witnessed Marksan pharma and Lupin being a multibagger stock.
Is synsyncom formulations ( syn) A good stock to buy?
Syncom Formulations is a Penny Stock and investing in penny stocks is said to be a riskier policy. In last one year it has lost its market value almost by 53\%. The promoters of the company are constantly reducing their stake.
What is Syncom formulations (India) Ltd?
Syncom Formulations (India) Ltd was originally incorporated as Syncom Formulations (India) Private Limited in the state of Maharashtra on June 21, 1988 under the Companies Act, 1956.
What is the market capitalisation of Syncom formulations?
The current market capitalisation of the company stands at Rs 251.37 crore. Syncom Formulations (India) Ltd was originally incorporated as Syncom Formulations (India) Private Limited in the state of Maharashtra on June 21, 1988 under the Companies Act, 1956.